Quiescence in Active and Inactive Non-Infectious, Intermediate, Posterior, or Panuveitis in Patients Treated with Adalimumab

被引：0
|
作者：
Landewe, Robert [1 ]
van der Horst-Bruinsma, Irene [2 ]
Tari, Samir [3 ]
Florentinus, Stefan [3 ]
Song, Alexandra P. [3 ]
Kron, Martina [4 ]
Pathai, Sophia [5 ]
Roseribaum, James T. [6 ,7 ]
机构：
[1] Univ Amsterdam, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Rheumatol, Amsterdam, Netherlands
[3] AbbVie Inc, N Chicago, IL USA
[4] Abbvie Deutschland GmbH & Co KG, Ludwigshafen, Germany
[5] AbbVie Ltd, Maidenhead, Berks, England
[6] Oregon Hlth & Sci Univ, Casey Eve Inst, Portland, OR 97201 USA
[7] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3077
引用
收藏
页数：3
相关论文
共 50 条
  • [1] QUIESCENCE IN ACTIVE AND INACTIVE NON-INFECTIOUS, INTERMEDIATE, POSTERIOR, OR PANUVEITIS IN PATIENTS TREATED WITH ADALIMUMAB: VISUAL I AND VISUAL II TRIALS
    Landewe, R.
    van der Horst-Bruinsma, I.
    Tari, S.
    Florentinus, S.
    Song, A.
    Kron, M.
    Pathai, S.
    Rosenbaum, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 403 - 403
  • [2] Adalimumab in Patients with Active and Inactive Non-infectious Uveitis
    Ohno, S.
    Nguyen, Q. D.
    Dick, A.
    Jaffe, G.
    Brezin, A.
    Song, A. P.
    Kron, M.
    Camez, A.
    Tari, S.
    [J]. SWISS MEDICAL WEEKLY, 2016, 146 : 8S - 8S
  • [3] Impact of adalimumab in patients with active non-infectious intermediate, posterior, and panuveitis in real-life clinical practice: HOPE study
    Pleyer, Uwe
    Al-Mutairi, Salem
    Murphy, Conor C.
    Hamam, Rola
    Hammad, Shereen
    Nagy, Orsolya
    Szepessy, Zsuzsanna
    Guex-Crosier, Yan
    Julian, Karina
    Habot-Wilner, Zohar
    Androudi, Sofia
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (12) : 1892 - 1899
  • [4] Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis
    Claudia Fabiani
    Antonio Vitale
    Giacomo Emmi
    Alice Bitossi
    Giuseppe Lopalco
    Jurgen Sota
    Silvana Guerriero
    Ida Orlando
    Marco Capozzoli
    Fiorella Fusco
    Francesco Rana
    Florenzo Iannone
    Bruno Frediani
    Mauro Galeazzi
    Lorenzo Vannozzi
    Gian Marco Tosi
    Luca Cantarini
    [J]. Clinical Rheumatology, 2019, 38 : 63 - 70
  • [5] Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis
    Fabiani, Claudia
    Vitale, Antonio
    Emmi, Giacomo
    Bitossi, Alice
    Lopalco, Giuseppe
    Sota, Jurgen
    Guerriero, Silvana
    Orlando, Ida
    Capozzoli, Marco
    Fusco, Fiorella
    Rana, Francesco
    Iannone, Florenzo
    Frediani, Bruno
    Galeazzi, Mauro
    Vannozzi, Lorenzo
    Tosi, Gian Marco
    Cantarini, Luca
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (01) : 63 - 70
  • [6] Adalimumab for the treatment of refractory active and inactive non-infectious uveitis
    Lee, Jonathan T. L.
    Yates, William B.
    Rogers, Sophie
    Wakefield, Denis
    McCluskey, Peter
    Lim, Lyndell L.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (12) : 1672 - 1678
  • [7] Long-Term Safety and Efficacy of Adalimumab in Patients with Non-Infectious Intermediate, Posterior, or Panuveitis in an Ongoing Open-Label Study
    Suhler, Eric B.
    Jaffe, Glenn J.
    Nguyen, Quan Dong
    Brezin, Antoine P.
    Zierhut, Manfred
    Vitale, Albert
    van Velthoven, Mirjam
    Adan, Alfredo
    Lim, Lyndell
    Kramer, Michal
    Schlaen, Ariel
    Fortin, Eric
    Muccioli, Cristina
    Goto, Hiroshi
    Kaburaki, Toshikatsu
    Camez, Anne
    Song, Alexandra P.
    Kron, Martina
    Tari, Samir
    Dick, Andrew D.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis
    Jabs, Douglas A.
    Van Natta, Mark L.
    Altaweel, Michael M.
    Dunn, James P.
    Lightman, Susan
    Thorne, Jennifer E.
    Holbrook, Janet T.
    Kempen, John H.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [9] A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults
    Squires, Hazel
    Poku, Edith
    Bermejo, Inigo
    Cooper, Katy
    Stevens, John
    Hamilton, Jean
    Wong, Ruth
    Denniston, Alastair
    Pearce, Ian
    Quhill, Fahd
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (68) : 1 - +
  • [10] TREATMENT OF ACTIVE AND INACTIVE NON-INFECTIOUS UVEITIS WITH ADALIMUMAB: AN AUSTRALIAN EXPERIENCE
    Lee, Jonathan
    Yates, William
    Rogers, Sophie
    McCluskey, Peter
    Lim, Lyndell
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 71 - 71
12345